Literature DB >> 29455272

The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999-2014.

Keiju S K Kontula1, Kirsi Skogberg2, Jukka Ollgren3, Asko Järvinen2, Outi Lyytikäinen3.   

Abstract

Few studies covering all patient groups and specialties are available regarding the outcome of nosocomial bloodstream infections (BSI). We analyzed the role of patient characteristics and causative pathogens of nosocomial BSIs reported by the hospitals participating in national surveillance in Finland during 1999-2014, in terms of outcome, with particular interest in those leading to death within 2 days (i.e. early death). National nosocomial BSI surveillance was laboratory-based and hospital-wide. Data on nosocomial BSIs was collected by infection control nurses, and dates of death were obtained from the national population registry with linkage to national identity codes. A total of 17,767 nosocomial BSIs were identified; 557 BSIs (3%) were fatal within 2 days and 1150 (6%) within 1 week. The 1-month case fatality was 14% (2460 BSIs), and 23% of the deaths occurred within 2 days and 47% within 1 week. The patients who died early were older than those who survived > 28 days, and their BSIs were more often related to intensive care. Gram-positive bacteria caused over half of the BSIs of patients who survived, whereas gram-negative bacteria, especially Pseudomonas aeruginosa, caused more often BSIs of patients who died early, and fungi BSIs of patients who died within 1 week. A significant portion of patients with nosocomial BSIs died early, which underlines the importance of rapid recognition of BSI. Hospital-wide surveillance data of causative pathogens can be utilized when composing recommendations for empiric antimicrobial treatment in collaboration with clinicians, as well as when promoting infection prevention.

Entities:  

Keywords:  Bloodstream infection; Case fatality; Early death; Nosocomial; Surveillance

Mesh:

Year:  2018        PMID: 29455272     DOI: 10.1007/s10096-018-3211-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  Risk factors for ineffective therapy in patients with bloodstream infection.

Authors:  Jay R McDonald; N Deborah Friedman; Jason E Stout; Daniel J Sexton; Keith S Kaye
Journal:  Arch Intern Med       Date:  2005-02-14

2.  Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital.

Authors:  Emilia Åttman; Janne Aittoniemi; Marjatta Sinisalo; Risto Vuento; Outi Lyytikäinen; Tommi Kärki; Jaana Syrjänen; Reetta Huttunen
Journal:  Leuk Lymphoma       Date:  2015-10-05

3.  Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.

Authors:  Marie-Laurence Lambert; Carl Suetens; Anne Savey; Mercedes Palomar; Michael Hiesmayr; Ingrid Morales; Antonella Agodi; Uwe Frank; Karl Mertens; Martin Schumacher; Martin Wolkewitz
Journal:  Lancet Infect Dis       Date:  2010-12-02       Impact factor: 25.071

4.  Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.

Authors:  Jesús Rodríguez-Baño; Encarnación Picón; Paloma Gijón; José Ramón Hernández; Jose M Cisneros; Carmen Peña; Manuel Almela; Benito Almirante; Fabio Grill; Javier Colomina; Sonia Molinos; Antonio Oliver; Carlos Fernández-Mazarrasa; Gemma Navarro; Ana Coloma; Lorena López-Cerero; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

5.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

Authors:  M B Edmond; S E Wallace; D K McClish; M A Pfaller; R N Jones; R P Wenzel
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

6.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.

Authors:  L Leibovici; I Shraga; M Drucker; H Konigsberger; Z Samra; S D Pitlik
Journal:  J Intern Med       Date:  1998-11       Impact factor: 8.989

7.  Nosocomial bloodstream infections in Finnish hospitals during 1999-2000.

Authors:  O Lyytikäinen; J Lumio; H Sarkkinen; E Kolho; A Kostiala; P Ruutu
Journal:  Clin Infect Dis       Date:  2002-06-18       Impact factor: 9.079

8.  Early deaths in bloodstream infections: a population-based case series.

Authors:  Keiju S K Kontula; Kirsi Skogberg; Jukka Ollgren; Asko Järvinen; Outi Lyytikäinen
Journal:  Infect Dis (Lond)       Date:  2016-01-14

9.  Epidemiology and outcome of nosocomial and community-onset bloodstream infection.

Authors:  D J Diekema; S E Beekmann; K C Chapin; K A Morel; E Munson; G V Doern
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms.

Authors:  J Ignacio Barrasa-Villar; Carlos Aibar-Remón; Purificación Prieto-Andrés; Rosa Mareca-Doñate; Javier Moliner-Lahoz
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

View more
  3 in total

1.  Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital - a five-year retrospective study.

Authors:  Ana Gorgulho; Ana Maria Grilo; Manuel de Figueiredo; Joana Selada
Journal:  Germs       Date:  2020-06-02

2.  Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria.

Authors:  Antonella Santoro; Erica Franceschini; Marianna Meschiari; Marianna Menozzi; Stefano Zona; Claudia Venturelli; Margherita Digaetano; Carlotta Rogati; Giovanni Guaraldi; Mical Paul; Inge C Gyssens; Cristina Mussini
Journal:  Open Forum Infect Dis       Date:  2020-09-30       Impact factor: 3.835

3.  Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020.

Authors:  Simon Brinkwirth; Olaniyi Ayobami; Tim Eckmanns; Robby Markwart
Journal:  Euro Surveill       Date:  2021-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.